Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC

Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC

A major part of non-small cell lung cancer (NSCLC) patients treated with mono- or multimodal concept develop therapy resistance. Despite the abundance of biomarkers investigated in the past, there is still a need for valid NSCLC biomarkers. Glycodelin, an immunosuppressive endometrial protein, has b...

Full description

Bibliographic Details
Main Authors: Marc A. Schneider, Thomas Muley, Rebecca Weber, Sabine Wessels, Michael Thomas, Felix J. F. Herth, Nicolas C. Kahn, Ralf Eberhardt, Hauke Winter, Gudula Heussel, Arne Warth, Christel Herold-Mende, Michael Meister
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Cancers
Subjects:
<i>PAEP</i>
glycodelin
NSCLC
early detection
follow-up biomarker
Online Access:https://www.mdpi.com/2072-6694/10/12/486

Internet

https://www.mdpi.com/2072-6694/10/12/486

Similar Items